Novartis Ag (NVS) Revenue (2009 - 2025)

Novartis Ag (NVS) has 15 years of Revenue data on file, last reported at $14.1 billion in Q2 2025.

• Quarterly Revenue rose 12.32% year-over-year to $14.1 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $73.1 billion (up 57.27% YoY) and the FY2025 annual result came in at $54.5 billion, up 8.38% from the prior year.
• Revenue declined to $14.1 billion in Q2 2025 per NVS's latest filing, from $24.3 billion in the prior quarter.
• The five-year high for Revenue was $25.4 billion in Q4 2021, with the low at $226.0 million in Q3 2021.
• Average Revenue over 5 years is $9.8 billion, with a median of $12.0 billion recorded in 2023.
• Year-over-year, Revenue surged 10382.23% in 2021 and slumped 99.0% in 2022.
• Novartis Ag's Revenue stood at $25.4 billion in 2021, then tumbled by 99.0% to $254.0 million in 2022, then surged by 8653.94% to $22.2 billion in 2023, then increased by 9.47% to $24.3 billion in 2024, then plunged by 42.26% to $14.1 billion in 2025.
• Business Quant data shows NVS's Revenue at $14.1 billion in Q2 2025, $24.3 billion in Q4 2024, and $12.5 billion in Q2 2024.